SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-06-007804
Filing Date
2006-06-16
Accepted
2006-06-16 16:33:40
Documents
6
Period of Report
2006-06-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y22361e8vk.htm 8-K 29494
2 EX-3.II: SECOND AMENDED AND RESTATED BYLAWS y22361exv3wii.htm EX-3.II 58599
3 EX-10.1: EMPLOYMENT AGREEMENT y22361exv10w1.htm EX-10.1 62086
4 EX-99.1: PRESS RELEASE y22361exv99w1.htm EX-99.1 12390
5 EX-99.2: PRESS RELEASE y22361exv99w2.htm EX-99.2 7668
6 GRAPHIC y22361y2236101.gif GRAPHIC 3758
  Complete submission text file 0000950123-06-007804.txt   177291
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 06910705
SIC: 2835 In Vitro & In Vivo Diagnostic Substances